NCT03038308 2024-06-04
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
Columbia University
Phase 1/2 Completed
Clinical Trials
8 trialsNCT05236829 2024-05-24
Exercise Capacity and Physical Activity Level in Prolactinoma Patients
Hacettepe University
Completed
NCT00939523 2020-01-22
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Cedars-Sinai Medical Center
Phase 2 Completed
NCT01504399 2018-08-22
Rhinological Outcomes in Endonasal Pituitary Surgery
St. Joseph's Hospital and Medical Center, Phoenix
Completed
NCT01620138 2016-08-22
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
Universidade Federal do Rio de Janeiro
Phase 2/3 Completed
NCT00697814 2008-06-16
Clomiphene in Males With Prolactinomas and Persistent Hypogonadism
Federal University of São Paulo
Phase 2 Completed
NCT00460616 2008-04-16
ValveCab
Federico II University
Completed
NCT00481299 2007-06-01
Insulin Resistance in Women With Prolactinoma
Universidade Federal do Rio de Janeiro
Completed